I hope investors start focusing their short term attention to developments other than COV. The COV news was not what Biomedreports.com led people to believe. The COV deal did not create instant gratification run up on POSC stock because of a buyout or deal that hit the ground running at full capacity.It will take time for those seeds to grow. Sorry for the cliche but..it is what it is.
I expect the investor update letter will shed some light on other irons in the fire.
Also it has been announced that the Pharma division will begin showing progress early 4th quarter which is right here.
POSC shareholders are invested in a company that is striving to be a billion dollar leader in their field. We are moving in the right direction with the business and I feel that the stock will soon follow.
Market Data 
Markets 
AI
